Inventor
Stanley J. Schmidt
Inventor
Chester Springs, PA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides16%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
10,975,056Substituted pyridines as inhibitors of DNMT120218,785,433'Quinoline derivatives as PI3 kinase inhibitors'20148,633,187'Quinoline derivatives as PI3 kinase inhibitors'20148,404,837'Quinoline derivatives as P13 kinase inhibitors'20138,138,347'Quinoline derivatives as PI3 kinase inhibitors'20126,995,261'4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors'20066,849,635'Sulfonamides'20056,624,166'Pyridazines as interleukin-1 converting enzyme inhibitors'20036,576,614'Peptide analogs as irreversible interleukin-1 protease inhibitors'20036,407,080'N-(pyrimidinyl)-aspartic acid analogs as interleukin-1 converting enzyme inhibitors'20026,162,800'N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors'20006,121,266'Pyridazines as interleukin-1.beta. converting enzyme inhibitors'20005,985,838'Peptide analogs as irreversible interleukin-1.beta. protease inhibitors'19995,677,283'.alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. converting enzyme inhibitors'19975,670,494'N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors'19975,639,745'Fused-bicyclic lactams as interleukin-1.beta. converting enzyme inhibitors'19975,585,357'Heteroaryloxymethyl ketones as interleukin-1.beta.converting enzyme inhibitors'19965,585,486'Peptidic ketones as interleukin-1.beta.-converting enzyme inhibitors'19965,552,400'Fused-bicyclic lactams as interleukin-1.beta. converting enzyme inhibitors'19965,462,939'Peptidic ketones as interleukin-1.beta.-converting enzyme inhibitors'19954,064,242'7-Acylamino-3-[1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl]-3-ceph em-4-carboxylic acids'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977Based in Ardmore, PA, US· patent location history
1995–1996Patents assigned to STERLING WINTHROP INC (3)· patent assignee history
1995–2006Based in Chester Springs, PA, US· patent location history
1999–2006Patents assigned to VERTEX PHARMA (7)· patent assignee history
2005Based in King of Prussia, PA, US· patent location history
2012–2014Patents assigned to GLAXOSMITHKLINE LLC (4)· patent assignee history
2012–2014Patents assigned to KNIGHT STEVEN DAVID (3)· patent assignee history
2012–2014Patents assigned to SCHMIDT STANLEY J (3)· patent assignee history
2012–2021Based in Collegeville, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 7 | 1999–2006 |
| GLAXOSMITHKLINE LLC | 4 | 2012–2014 |
| KNIGHT STEVEN DAVID | 3 | 2012–2014 |
| SCHMIDT STANLEY Jself | 3 | 2012–2014 |
| STERLING WINTHROP INC | 3 | 1995–1996 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chester Springs, Pennsylvania, US | 14 | 1995–2006 |
| Collegeville, Pennsylvania, US | 5 | 2012–2021 |
| King of Prussia, Pennsylvania, US | 1 | 2005 |
| Ardmore, Pennsylvania, US | 1 | 1977 |